Dose-dependent effects of Δ9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat

Synapse

Volumn 45, Issue 2, 2002, Pages 134-142

  Freedland, Cory S ^a   Whitlow, Christopher T ^a   Miller, Mack D ^a   Porrino, Linda J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

14C 2 deoxyglucose; Cannabinoid; CB1; SR141716A

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARBON 14; DEOXYGLUCOSE; DRONABINOL; GLUCOSE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN METABOLISM; BRAIN PROTECTION; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE UTILIZATION; LIMBIC SYSTEM; MALE; METABOLIC INHIBITION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SENSORY SYSTEM;

ANIMALS; AUTORADIOGRAPHY; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; MALE; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0036307986     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10089     Document Type: Article

References (41)

1. Cannabis: Pharmacology and toxicology in animals and humans
2. Cannabinoid-induced alterations in regional cerebral blood flow in the rat
3. A selective inverse agonist for central cannabinoid receptor inhibits mitogen- activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions
4. SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats
5. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism
6. Effects of anandamide on cannabinoid receptors in rat brain membranes
7. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice
8. Adaptation of the quantitative 2-[14C]deoxyglucose method for use in freely moving rats
9. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
10. Effects of SR141716A on ethanol and sucrose self-administration
11. Metabolic mapping of the effects of the acute administration of the cannabinoid receptor antagonist SR141716A in rat
12. Isolation, structure and partial synthesis of an active constituent of hashish
13. Delta 9-tetrahydrocannabinol alters flow of blood to subcortical areas of the conscious rat brain
14. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats
15. Cannabinoid receptor localization in brain
16. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
17. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716
18. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism
19. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells
20. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
21. Delta 9-tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain
22. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections
23. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system
24. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain
25. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture
26. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats
27. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity
28. Cannabinoid penetration into mouse brain as determined by ex vivo binding
29. Metabolic mapping of the effects of WIN 55212-2 intravenous administration in the rat
30. Functional consequences of acute cocaine treatment depend on route of administration
31. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat
32. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain
33. Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat
34. Activational role of cannabinoids on movement
35. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
36. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
37. Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat
38. Correlation between the dose and development of acute tolerance to the hypothermic effect of THC
39. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat
40. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats